Some community hospitals in Beijing Pfizer's new crown oral drug arrived, the use of drugs subject to strict evaluation

Read Time:4 Minute, 35 Second

“(Pfizer) New Crown oral drug just arrived yesterday, the first batch arrived 26 boxes, need to buy with a prescription, the current medical insurance payment price of 1980 yuan / box.” On December 30, the director of a community health service center in Shijingshan District, Beijing, told the People’s Daily Health Client reporter that, according to current requirements, patients applying for the drug must provide a confirmed medical history of New Crown or provide proof of positive nucleic acid or on-site antigen testing, and the onset of the disease within five days, in general, patients over the age of 65 and combined with underlying disease, which may be at risk of developing into a serious hospitalization The drug is indicated.

The reporter consulted several community health service centers in Beijing, including Chaoyang District, Dongcheng District, Fengtai District, and Shijingshan District, and learned that the first batch of Pfizer New Crown oral medications requested by some community health service centers have arrived, but the quantity is limited, and the prescriptions for the medications are subject to strict evaluation before they can be prescribed.

Pfizer New Crown Oral Medication

The first batch arrived in limited quantities, and most community hospitals are still waiting for notification

According to the “urgent notice on the organization of the city’s community health service institutions medical staff training in the application of antiviral drugs” issued by Beijing on December 25, according to the city’s unified deployment, the recent unified distribution of antiviral drugs nematovir/ritonavir tablets (Paxlovid) to the community health service centers, by community doctors to guide the district’s new crown patients to take for antiviral treatment.

On December 30, staff from several community health service centers in Dongcheng District and Chaoyang District also confirmed to the People’s Daily Health Client reporter that the first batch of New Crown oral medication had just arrived. “The first batch arrived in limited quantities, each community hospital at most a dozen or 20 boxes. And not all community hospitals are uniformly arriving, most of them are still waiting for notification, and patients with medication needs are advised to call their community first to find out more before going there.”

Confirmed patients must be within 5 days of onset and pass a rigorous evaluation

“On the use of the new crown small molecule oral drugs, the national and municipal and district health care committees have successively unified training, must meet the appropriate indications to open, on this basis, yesterday after the arrival of drugs, our community health service centers also held an emergency training session, unified the process of prescribing drugs, the purpose is to allow these drugs to patients with real needs. ” Shijingshan District, a community health service center director told reporters.

According to him, the new crown oral drugs need to be purchased directly by prescription, but the prescription must be strictly assessed. “First of all, after the patient has registered at the community hospital, the general practitioner who receives the patient will make the first round of assessment of the patient’s specific condition, and after passing the assessment, the second round of comprehensive assessment will be made by the doctor team leader, the director of the community health service center and the pharmacy team leader. Only after both assessments are passed can the new oral medication be purchased in the hospital, and the patient will be provided with detailed instructions and post-medication follow-up after the prescription.”

The staff of a community health service center in Chaoyang District also told reporters that first of all, patients must provide their own proof of positive nucleic acid or antigen test results, and must come to the hospital within 5 days of the onset of the disease, and if accompanied by family members, they must also provide the family’s ID card, the patient’s ID card and the patient’s medical insurance card, in addition, they must also provide the patient’s detailed past medical history, and the doctor will conduct a comprehensive assessment to determine The doctor will make a comprehensive assessment to determine whether the drug is suitable.

The significance of the new crown oral drug is to prevent serious illness, beware of interactions with other drugs

“At our hospital, there are strict indications for the use of Neocon oral medications, which are small molecule antiviral drugs for early infection, especially for older adults with underlying disease that may progress to severe disease. For this group, they can be actively used under the guidance of a physician in order to prevent severe disease. However, once it reaches the stage of severe and critical illness, when a full range of treatment is more necessary, the use of small molecule antiviral drugs alone does not make much sense.” Zhou Qianyun, director of the Department of Critical Care Medicine at Peking University Shougang Hospital, said in an interview.

“In addition, patients with new coronary heart disease are generally combined with serious underlying diseases, and antiviral small-molecule drugs may interact with drugs used to treat underlying diseases such as hypertension and coronary heart disease. This also means that when taking antiviral small molecule drugs, some patients must stop using the underlying disease treatment drugs, for patients with serious underlying disease, the use of antiviral small molecule drugs may instead trigger a great risk, should be guided by a professional physician after a thorough understanding of the medical history.” A respiratory critical care specialist at a tertiary hospital in Beijing, who did not want to be named, told reporters.